Supratek Pharma Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for SP1049C for the treatment of metastatic adenocarcinoma …

Harvard Apparatus has announced its acquisition of Panlab s.l. of Barcelona, Spain a distributor and manufacturer of products and software for the life sciences researcher, primarily in the …

ARIUS Research Inc. announced that new findings have been presented from its Trop-2 and CD59 antibody programs. “Both our Trop-2 and CD59 antibody programs have demonstrated novel approaches in …

Biota Holdings announced that it had received written notification from GlaxoSmithKline (GSK) that indicative royalties for Relenza were AU$4.5m during the three months ended 30 September 2007. GSK …

Signals are generated for tomorrows markets based on todays closing prices and daily statistics.

Look for Gold to pop up to these levels in the very near term…

Genzyme Corp. (NASDAQ: GENZ) and Sunway Biotech Co. Ltd. announced that they will collaborate to manufacture, develop, and commercialize the experimental gene therapy Ad2/HIF-1a in China. The product …

Oxford BioMedica and Sigma-Aldrich announced that they received a key order confirming the strength and validity of intellectual property owned by Oxford BioMedica and licensed exclusively in the …

Ipsat Therapies announced that the Ipsat P1A phase IIb study met both primary endpoints. Ipsat P1A is the most advanced of Ipsat’s portfolio of beta-lactamases, specifically designed to inactivate …

Amorfix Life Sciences announced the results from the testing of a blinded panel of blood samples from scrapie infected sheep. Amorfix correctly identified 18 out of 20 individual sheep blood samples …